A carregar...

Getting personal with myelodysplastic syndromes: is now the right time?

INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and guide therapy decisions. Next generation sequencing (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Expert Rev Hematol
Main Authors: Chokr, Nora, Pine, Alexander B., Bewersdorf, Jan Philipp, Shallis, Rory M., Stahl, Maximilian, Zeidan, Amer M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540985/
https://ncbi.nlm.nih.gov/pubmed/30977414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1592673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!